BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 28241836)

  • 1. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma.
    Liu L; Bi N; Wu L; Ding X; Men Y; Zhou W; Li L; Zhang W; Shi S; Song Y; Wang L
    Mol Cancer; 2017 Feb; 16(1):50. PubMed ID: 28241836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR-29c-3p.
    Jin Y; Cao J; Hu X; Cheng H
    J Clin Lab Anal; 2021 Dec; 35(12):e24106. PubMed ID: 34762771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
    Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
    Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The knockdown of MALAT1 inhibits the proliferation, invasion and migration of hemangioma endothelial cells by regulating MiR-206 / VEGFA axis.
    Wang S; Ren L; Shen G; Liu M; Luo J
    Mol Cell Probes; 2020 Jun; 51():101540. PubMed ID: 32084582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
    Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [miR-144-3p Inhibits the Invasion and Metastasis of Lung Adenocarcinoma Cells 
by Targeting IRS1].
    Bai J; Hu Y; Chen X; Chen L; Zhang L; Yin C; Li H
    Zhongguo Fei Ai Za Zhi; 2021 May; 24(5):323-330. PubMed ID: 34034455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-29c-3p represses the angiogenesis of esophageal squamous cell carcinoma by targeting SERPINH1 to regulate the Wnt signaling pathway.
    Wei D; Ma Z; Zhu T; Wang H; Wang B; Fu L; Yu G
    Acta Cir Bras; 2023; 38():e385223. PubMed ID: 38055382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
    Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
    Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-608 exerts tumor suppressive function in lung adenocarcinoma by directly targeting MIF.
    Yu HX; Wang XM; Han XD; Cao BF
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4908-4916. PubMed ID: 30070326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
    Wang M; Zhang J; Tong L; Ma X; Qiu X
    Int J Clin Exp Pathol; 2015; 8(11):14110-20. PubMed ID: 26823724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis via VEGFA in upper tract urothelial carcinoma.
    Wang CS; Lee YC; Jhan JH; Li WM; Chang LL; Huang AM; Lin HH; Wu YR; Hsu WC; Ke HL
    J Gene Med; 2024 Jan; 26(1):e3616. PubMed ID: 38049938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.
    Niu J; Sun Y; Guo Q; Niu D; Liu B
    Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
    Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
    Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circular RNA 001971/miR-29c-3p axis modulates colorectal cancer growth, metastasis, and angiogenesis through VEGFA.
    Chen C; Huang Z; Mo X; Song Y; Li X; Li X; Zhang M
    J Exp Clin Cancer Res; 2020 May; 39(1):91. PubMed ID: 32430042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PVT1 Promotes Angiogenesis by Regulating miR-29c/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway in Non-Small-Cell Lung Cancer (NSCLC).
    Mao Z; Xu B; He L; Zhang G
    Med Sci Monit; 2019 Jul; 25():5418-5425. PubMed ID: 31326971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
    Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
    Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.